UNC Rex Cancer Center of Wakefield — Raleigh, North Carolina

UNC Rex Cancer Center of Wakefield is a clinical research site located in Raleigh, North Carolina, United States 27614.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

UNC Rex Cancer Center of Wakefield has participated in 8 clinical trials with 5 currently active.

Therapeutic areas: Anatomic Stage IV Breast Cancer American Joint Committee on Cancer (AJCC) v8, Metastatic Breast Carcinoma, Metastatic Malignant Neoplasm in the Bone.

Sponsors: NRG Oncology, ECOG-ACRIN Cancer Research Group, SWOG Cancer Research Network.

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UNC Rex Cancer Center of Wakefield?

UNC Rex Cancer Center of Wakefield has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UNC Rex Cancer Center of Wakefield conducted?

UNC Rex Cancer Center of Wakefield has 8 clinical trials on record, with 5 currently active. Their work covers Anatomic Stage IV Breast Cancer American Joint Committee on Cancer (AJCC) v8, Metastatic Breast Carcinoma, Metastatic Malignant Neoplasm in the Bone.

Is UNC Rex Cancer Center of Wakefield accredited by Crixeo Health?

Yes — UNC Rex Cancer Center of Wakefield holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about UNC Rex Cancer Center of Wakefield?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.